PATL2复合杂合变异致卵母细胞成熟障碍

doi:10.16352/j.issn.1001-6325.2022.01.004

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (1): 51-55.doi: 10.16352/j.issn.1001-6325.2022.01.004

PATL2复合杂合变异致卵母细胞成熟障碍

霍明珠, 张轶乐, 徐家伟, 史昊, 刘益栋, 牛文彬^*

郑州大学第一附属医院生殖医学中心河南省生殖与遗传重点实验室,河南郑州 450052

收稿日期:2021-04-22 修回日期:2021-06-03 出版日期:2022-01-05 发布日期:2022-01-05
通讯作者: ^* wenbinniu2004@163.com
基金资助:
国家自然科学基金(81701443,31970799);中华医学会临床医学科研专项资金生殖医学青年医师研究与发展项目(17020250694)

Compound heterozygous variation of PATL2 causes oocyte maturation defect

HUO Ming-zhu, ZHANG Yi-le, XU Jia-wei, SHI Hao, LIU Yi-dong, NIU Wen-bin^*

Henan Key Laboratory of Reproduction and Genetics, Center for Reproductive Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China

Received:2021-04-22 Revised:2021-06-03 Online:2022-01-05 Published:2022-01-05
Contact: ^* wenbinniu2004@163.com

摘要/Abstract

摘要： 目的探讨1例原发不孕伴卵母细胞成熟障碍患者的遗传学病因。方法对患者DNA进行全外显子组测序(WES),对WES检测到的阳性位点进行Sanger测序验证,并对该位点进行生物学信息分析。结果 WES检测到患者PATL2第14和13外显子c.1 374A＞G(p.Ile458Met)及c.1 289_1 291delTCC(p.Leu430del) 的复合杂合变异,母亲携带c.1 289_1 291delTCC(p.Leu430del) 杂合变异,父亲携带c.1 374A＞G(p.Ile458Met)的杂合变异。结论患者PATL2复合杂合变异可能是其卵母细胞成熟障碍而不孕的遗传学病因。

关键词: PATL2基因, 卵母细胞成熟障碍

Abstract: Objective To investigate the genetic etiology of a patient with primary infertility and oocyte maturation defect. Methods Whole exome sequencing (WES) was carried out on patient's DNA to detect potential pathologic variants. The positive sites detected by WES were verified by Sanger sequencing, and the bioinformatics analysis of the mutation was analyzed. Results The patient was found to harbor compound heterozygous variants of the PATL2 in exon 14 and 13 c.1 374A＞G (p.Ile458Met) and c.1 289_1 291delTCC (p.Leu430del), which were respectively inherited from her father and mother. Conclusions The compound heterozygous variation of PATL2 may be the genetic mechanism to explain infertility resulted from the disturbance of oocyte maturation.

Key words: PATL2 gene, oocyte maturation defect

中图分类号:

R394

霍明珠, 张轶乐, 徐家伟, 史昊, 刘益栋, 牛文彬. PATL2复合杂合变异致卵母细胞成熟障碍[J]. 基础医学与临床, 2022, 42(1): 51-55.

HUO Ming-zhu, ZHANG Yi-le, XU Jia-wei, SHI Hao, LIU Yi-dong, NIU Wen-bin. Compound heterozygous variation of PATL2 causes oocyte maturation defect[J]. Basic & Clinical Medicine, 2022, 42(1): 51-55.

参考文献

[1]Mehlmann LM. Stops and starts in mammalian oocytes: recent advances in understanding the regulation of meiotic arrest and oocyte maturation[J]. Reproduction, 2005, 130: 791-799.
[2]Szöllösi D. Oocyte maturation and paternal contribution to the embryo in mammals[J]. Curr Top Pathol, 1976, 62:9-27.
[3]Beall S, Brenner C, Segars J. Oocyte maturation failure: a syndrome of bad eggs[J]. Fertil and steril, 2010, 94: 2507-2513.
[4]Maddirevula S, Coskun S, Alhassan S, et al. Female infertility caused by mutations in the oocyte-specific translational repressor PATL2[J]. Am J Hum Genet, 2017, 101: 603-608.
[5]Radford HE, Meijer HA, de Moor CH. Translational control by cytoplasmic polyadenylation in Xenopus oocytes[J]. Biochim Biophys Acta, 2008, 1779: 217-229.
[6]Nakamura Y, Tanaka KJ, Miyauchi M, et al. Transla-tional repression by the oocyte-specific protein P100 in Xenopus[J]. Dev Biol, 2010, 344: 272-283.
[7]Liu Z, Zhu L, Wang J, et al. Novel homozygous mutations in PATL2 lead to female infertility with oocyte maturation arrest[J]. J Assist Reprod Genet, 2020, 37: 841-847.
[8]Chen B, Zhang Z, Sun X, et al. Biallelic mutations in PATL2 cause female infertility characterized by oocyte maturation arrest[J]. Am J Hum Genet, 2017, 101: 609-615.
[9]Christou-Kent M, Kherraf ZE, Amiri-Yekta A, et al. PATL2 is a key actor of oocyte maturation whose invalidation causes infertility in women and mice[J]. EMBO Mol Med, 2018, 10: e8515.doi:10.15252.
[10]Huang L, Tong X, Wang F, et al. Novel mutations in PATL2 cause female infertility with oocyte germinal vesicle arrest[J]. Hum Reprod, 2018, 33: 1183-1190.
[11]Rother RP, Frank MB, Thomas PS. Purification, primary structure, bacterial expression and subcellular distribution of an oocyte-specific protein in Xenopus[J]. Eur J Biochem, 1992, 206: 673-683.
[12]Wu L, Chen H, Li D, et al. Novel mutations in PATL2: expanding the mutational spectrum and corresponding phenotypic variability associated with female infertility[J]. J Hum Genet, 2019, 64: 379-385.
[13]Zhang Z, Li B, Fu J, et al. Bi-allelic missense pathogenic variants in TRIP13 cause female infertility characterized by oocyte maturation arrest[J]. Am J Hum Genet, 2020, 107: 15-23.

[1]	张磊, 纪培丽, 乐偲, 赵秀丽, 刘雅萍, 陈丽萌. 翻转课堂结合案例中心教学法在医学遗传学课程中的应用[J]. 基础医学与临床, 2024, 44(9): 1331-1334.
[2]	刘思邑, 杨玉姣, 杨涛, 赵秀丽. 结节性硬化症5个家系致病变异的鉴定[J]. 基础医学与临床, 2024, 44(3): 361-367.
[3]	刘爱霞, 张浩, 孙杰, 杨丽华, 赵晓涛. GPS2对肝癌细胞系MHCC-97H增殖、迁移与侵袭的调控作用[J]. 基础医学与临床, 2023, 43(12): 1784-1791.
[4]	张亮亮, 赵程锦, 周煜虎, 曹博, 段明明, 冯阳阳. LncRNA FGD5-AS1调节miR-93-5p/BMP2轴促进人骨髓间充质干细胞成骨分化[J]. 基础医学与临床, 2023, 43(8): 1179-1185.
[5]	寇玉辉, 叶菜英, 邢成锋. Blau综合征的研究进展[J]. 基础医学与临床, 2022, 42(12): 1945-1949.
[6]	滕聪聪, 徐咏梅, 唐树萍, 李勇, 杨阳, 龙岚, 张杰. 云南省德宏州傣族育龄人群地中海贫血流行病学调查[J]. 基础医学与临床, 2022, 42(10): 1504-1508.
[7]	郭婧, 李亚洁, 牟寒霜. LncRNA FGD5-AS1靶向miR-106a-5p减轻ox-LDL诱导的HUVECs损伤[J]. 基础医学与临床, 2022, 42(5): 768-775.
[8]	张妍, 朱孟雯, 刘桐, 杨圣, 梁戈玉. N6-甲基腺苷(m6A)RNA修饰在生殖系统疾病中作用的研究进展[J]. 基础医学与临床, 2021, 41(9): 1347-1351.
[9]	姜学东, 李文雅. Erastin诱导人非小细胞肺癌细胞系A549凋亡[J]. 基础医学与临床, 2021, 41(9): 1313-1317.
[10]	姚涵, 徐文彬, 王冬来. 抗肿瘤药物FTY720对p53依赖的基因转录调控[J]. 基础医学与临床, 2021, 41(3): 311-317.
[11]	李明阳, 王淑霞, 赵静苗, 王秋萍, 陈凭, 金华, 胡继宏. 5-Aza诱导BM-MSCs移植对大鼠心肌梗死面积、相关细胞因子及钾离子通道蛋白的影响[J]. 基础医学与临床, 2021, 41(1): 20-26.
[12]	高东晓, 刘丹, 郭强, 罗瑛, 刘静. 生物钟在肿瘤调控中的研究进展[J]. 基础医学与临床, 2020, 40(11): 1561-1564.
[13]	米亚静, 张妮, 冯浩, 刘洁, 苟兴春, 景晓红. 医学遗传学课程建设中强化伦理素质培养的探索[J]. 基础医学与临床, 2020, 40(10): 1435-1438.
[14]	倪安妮, 梁清洋, 姚鸿飞, 李根亮, 唐玉莲. 花生四烯酸代谢基因对小鼠肝细胞癌中环氧化酶P450途径的影响[J]. 基础医学与临床, 2020, 40(8): 1053-1058.
[15]	胡景岑, 李链, 王淑瑜, 许磊, 杨德伦, 韩丽媛, 许国栋. SHMT1基因启动子甲基化与缺血性卒中相关[J]. 基础医学与临床, 2020, 40(4): 451-455.

PATL2复合杂合变异致卵母细胞成熟障碍

Compound heterozygous variation of PATL2 causes oocyte maturation defect

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价